Julia M. Grottenthaler - Publications

Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI Registry.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 13, 2025

Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 09, 2025

IgA-autoantibodies to histone 2B allow to differentiate between alcohol- and metabolic dysfunction-associated steatotic liver disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 09, 2024

Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.

Journal: Hepatology (Baltimore, Md.)

Published: December 13, 2023

Treating hepatitis D with bulevirtide - Real-world experience from 114 patients.

Journal: JHEP reports : innovation in hepatology

Published: November 06, 2022

Dynamics of glucose metabolism after liver transplantation: prediabetes as a window of opportunity for patient survival and long-term kidney function.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: April 29, 2021

Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine Malignancies.

Journal: Cancers

Published: March 31, 2021

Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation - development of a risk score.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: March 16, 2021

Impact of the COVID-19 pandemic on an interdisciplinary endoscopy unit in a German "hotspot" area: a single center experience.

Journal: Surgical endoscopy

Published: June 22, 2020

Antibodies to the Muscarinic Acetylcholine Receptor M3 in Primary Biliary Cholangitis Inhibit Receptor Function on Cholangiocytes.

Journal: Frontiers in immunology

Published: March 06, 2020

Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers.

Journal: European journal of gastroenterology & hepatology

Published: February 27, 2019

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.

Journal: PloS one

Published: March 12, 2018